Cardiovascular Diseases Clinical Trial
Official title:
Partnership Programs to Reduce Cardiovascular Disparities - Heart Failure Disparities in Native Hawaiians
The purpose of this study is to improve cardiovascular disease (CVD) outcomes in racial and ethnic minorities in Hawaii.
BACKGROUND:
While there has been great progress in reducing CVD morbidity and mortality in the U.S. over
the past 40 years, some minority groups have not benefitted from this progress, and continue
to have lower life expectancy and higher CVD morbidity. On average, minorities have more
limited access to medical care, receive less aggressive care, and receive fewer diagnostic
and therapeutic cardiac procedures than non-minority populations. Additionally, most
minority groups adhere poorly to prescribed medical regimens and often present to emergency
departments rather than primary care physicians for complications of advanced chronic CVD
conditions. Thus, research to reduce health disparities by improving CVD outcomes in
minorities offers potential for a substantial positive impact on public health. Academic
medical centers and institutions that are capable of carrying out such research, however,
often lack access to minority patients and have difficulty gaining the trust of those they
are able to treat. Minority communities often report greater satisfaction when receiving
care from minority providers and are reluctant to receive treatment outside their minority
healthcare serving systems.
In general, minorities have high rates of elevated cholesterol, hypertension, cigarette
smoking, obesity, metabolic syndrome, and diabetes. Other behavioral, environmental, and
occupational risk factors for cardiovascular diseases, such as sleep problems are also
common among minorties. These risk factors all contribute to excess CVD morbidity and
mortality. Heart failure (HF) is also a major public health problem. The impact of HF on
minority populations, such as Native Hawaiians and other Pacific peoples, is unknown. Native
Hawaiians are known to have high rates of risk factors for HF and one of the highest rates
of CVD mortality in the U.S. The causes of minority health disparities are complex and are
not understood completely. Although evidence of genetic, biologic, and environmental factors
is well documented, poor outcomes are also attributed to incomplete treatment. Such
treatment may be due to limited access to health care or, in some cases, break-down of the
medical system or failure of the physician and/or patient to allow for optimal health care,
even when access is not impaired. The complex interactions of behavior, socio-economic
status (SES), culture, and ethnicity are important predictors of health outcomes and sources
of health disparities. Despite efforts to elucidate genetic and environmental risk factors
and to promote cardiovascular health in high-risk populations, trends in CVD outcomes
suggest that CVD health disparities continue to widen.
The Partnerships Program to Reduce Cardiovascular Health Disparities involves collaboration
between research-intensive medical centers (RIMCs) that have a track record of NIH-supported
research and patient care and minority healthcare serving systems (MSSs) that lack a strong
research program. Each Partnership Program will design and carry out multiple
interdisciplinary research projects that investigate complex biologic, behavioral, and
societal factors that contribute to CVD health disparities and facilitate clinical research
within the MSS. The aim will be to improve CVD outcomes and reduce health disparities.
Additionally, each program will provide reciprocal educational and skills development
programs to train investigators to conduct research that is aimed at reducing cardiovascular
disparities, thereby enhancing research opportunities and enriching cultural sensitivity and
cardiovascular research capabilities at both institutions.
The Request for Applications for Partnership Programs to Reduce Cardiovascular Disparities
was released in September, 2003. The awards were made in September, 2004.
DESIGN NARRATIVE:
To address heart failure disparities among native Hawaiians and Pacific peoples, a
partnership program, the HF Disparities Program (HFD), will be established between the Queen
Emma Clinic (QEC) and the Department of Native Hawaiian Health. Partners of the HFD Program
include tha following: MedStar Research Institute, Oahu-based Community Health Centers
(CHCs), and the Hawaii EXPORT Center, an NIH-funded initiative addressing
diabetes-associated disparities in native Hawaiians and Pacific peoples. The HFD Program
will address the following aims: determine the reliability and validity of echocardiograms
performed by community-based health workers compared to a professionally trained sonographer
as the "gold standard"; determine if a culturally competent educational program for heart
failure reduces HF hospitalizations and mortality compared to usual care; characterize
ethnic differences in the HF syndrome in hospitalized native Hawaiians and Pacific peoples
compared to Caucasians; construct HF pedigrees using probands identified at the Queen Emma
Clinic for a future HF linkage study in native Hawaiians and Pacific peoples; educate
community-based health workers to perform echocardiography scans for the detection of HF in
a high risk population of native Hawaiians and Pacific peoples; and train new investigators
to conduct research focused on CVD disparities in general, and HF in particular. By
achieving these aims, the HFD Program will improve access to HF care at Community Health
Centers that serve native Hawaiians and Pacific peoples, fill a gap in knowledge of CVD
disparities in native Hawaiians and Pacific peoples, and provide a foundation for future
studies on genetic determinants of HF.
;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|